Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT03049332
Eligibility Criteria:
Inclusion Criteria:
Inclusion criteria for HIV+ women.
* be at least 18 years of age,
* be able to give informed consent for the study and to cognitively participate,
* be receiving clinical care at Ditan Hospital and SPHCC,
* have been diagnosed with HIV within the past 12 months,
* have disclosed their status to at least one family member and willing to invite that family member to the intervention,
* be well enough to attend counseling sessions at the hospital, and
* be able to attend follow-up visits at the hospital.
Inclusion criteria for family members.
* be 18 years of age,
* be able to give informed consent for the study and to cognitively participate,
* have a female family member who is HIV+, and is currently receiving clinical care at Ditan Hospital and SPHCC,
* be a family member who are taking care of the female HIV+ family member,
* be well enough to attend counseling sessions at the hospital, and
* be able to attend follow-up visits at the hospital.
Exclusion Criteria:
Exclusion criteria for HIV+ women
* history of an affective illness such as depression or bipolar disease,
* are under age 18, or
* are unwilling or unable to bring a family member to participate in the study.
Exclusion criteria for family members.
* have a history of an affective illness such as depression or bipolar disease,
* are under age 18,
* or are unwilling or unable to come with their HIV+ family member to participate the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03049332
Study Brief:
Protocol Section:
NCT03049332